Fundraising FoxNervmyo
1 known investors
Find your way into Nervmyo
Sign up to see every warm intro you have to Nervmyo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nervmyo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NervMyo Therapeutics develops a long-acting injectable delivery system combining a FDA-approved biologic (IGF-1) to improve nerve regrowth and prevent muscle wasting following peripheral nerve injury. The company targets nerve injury patients requiring regenerative therapeutics.
Founders & leadership
E
EricaCEO + Co-Founder
S
SamiCo-Founder
Investors · 1
Frequently asked questions
- What does Nervmyo do?
- NervMyo Therapeutics develops a long-acting injectable delivery system combining a FDA-approved biologic (IGF-1) to improve nerve regrowth and prevent muscle wasting following peripheral nerve injury. The company targets nerve injury patients requiring regenerative therapeutics.
- Who founded Nervmyo?
- Nervmyo was founded by Erica, Sami.
- Who are Nervmyo's investors?
- Nervmyo's investors include The Innovation Space.